Evidence map›Paper›PMID 34577632›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Engineering Mitochondriotropic Carbon Dots for Targeting Cancer Cells.

Archontia Kaminari, Eleni Nikoli, Alexandros Athanasopoulos, Elias Sakellis, Zili Sideratou, Dimitris Tsiourvas

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Recent Advances in Carbon Dots forFrontiers in chemistry · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Archontia KaminariNational Centre for Scientific Research "Demokritos", Institute of Nanoscience and Nanotechnology, 15310 Aghia Paraskevi, Greece.ORCID 0000-0003-4271-4450
Eleni NikoliNational Centre for Scientific Research "Demokritos", Institute of Nanoscience and Nanotechnology, 15310 Aghia Paraskevi, Greece.
Alexandros AthanasopoulosNational Centre for Scientific Research "Demokritos", Institute of Biosciences and Applications, 15310 Aghia Paraskevi, Greece.
Elias SakellisNational Centre for Scientific Research "Demokritos", Institute of Nanoscience and Nanotechnology, 15310 Aghia Paraskevi, Greece.ORCID 0000-0002-2361-3382
Zili SideratouNational Centre for Scientific Research "Demokritos", Institute of Nanoscience and Nanotechnology, 15310 Aghia Paraskevi, Greece.ORCID 0000-0002-9314-2520
Dimitris TsiourvasNational Centre for Scientific Research "Demokritos", Institute of Nanoscience and Nanotechnology, 15310 Aghia Paraskevi, Greece.
National Centre of Scientific Research "Demokritos" · GR

Funding

General Secretariat for Research and Technology MIS 5002567General Secretariat for Research and Technology MIS 5002755General Secretariat for Research and Technology MIS 5002772NCSR Demokritos EE11968
6 · The paper itself

Abstract

Aiming to understand and enhance the capacity of carbon dots (CDs) to transport through cell membranes and target subcellular organelles-in particular, mitochondria-a series of nitrogen-doped CDs were prepared by the one-step microwave-assisted pyrolysis of citric acid and ethylenediamine. Following optimization of the reaction conditions for maximum fluorescence, functionalization at various degrees with alkylated triphenylphosphonium functional groups of two different alkyl chain lengths afforded a series of functionalized CDs that exhibited either lysosome or mitochondria subcellular localization. Further functionalization with rhodamine B enabled enhanced fluorescence imaging capabilities in the visible spectrum and allowed the use of low quantities of CDs in relevant experiments. It was thus possible, by the appropriate selection of the alkyl chain length and degree of functionalization, to attain successful mitochondrial targeting, while preserving non-toxicity and biocompatibility. In vitro cell experiments performed on normal as well as cancer cell lines proved their non-cytotoxic character and imaging potential, even at very low concentrations, by fluorescence microscopy. Precise targeting of mitochondria is feasible with carefully designed CDs that, furthermore, are specifically internalized in cells and cell mitochondria of high transmembrane potential and thus exhibit selective uptake in malignant cells compared to normal cells.

Indexed as

bioimagingcancer cellscarbon dotsmembrane potentialmitochondrial targeting

Identifiers

PMID34577632
PMCPMC8470554
OpenAlexW3201126704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.